SENATE Blue Ribbon probers on Sunday faced another challenge to their ongoing investigation of alleged anomalies in multibillion-peso procurement of pandemic-related supplies. This, after a Pharmally Pharmaceuticals Corp. executive earlier tagged as a potenti…